scRNA-seq of melanoma cells isolated from patient-derived xenograft mouse models treated with BRAF/MEK inhibitors identified four transcriptional states with differential MITF activity representative of the pigmented, invasive, neural crest stem cell and starved phenotypes. This evidence concerns the gene BRAF and melanoma.